Safety risks associated with sulfite-containing compounded drugs
Jun 5, 2024 · FDA has received reports of allergic-type reactions potentially related to sulfite-containing compounded drugs. FDA is alerting health care professionals, compounders and patients about the …
FDA requires warning about rare but severe itching after stopping long
May 16, 2025 · FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names)
Know Which Medication Is Right for Your Seasonal Allergies
Jun 25, 2024 · Allergy Medicines for Children Always read the Drug Facts Label before buying a nonprescription medicine for you or your children.
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
The FDA approved the first nasal spray for the emergency treatment of allergic reactions in adult and certain pediatric patients.
Food Allergies | FDA - U.S. Food and Drug Administration
Sep 22, 2025 · To protect people with food allergies, FDA enforces regulations requiring companies to list ingredients on packaged foods.
Compounding and the FDA: Questions and Answers | FDA
Sep 16, 2025 · A drug may be compounded for a patient who cannot be treated with an FDA-approved medication, such as a patient who has an allergy to a certain dye and needs a medication to be …
Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication
Jan 22, 2025 · Copaxone, Glatopa (glatiramer acetate): Drug Safety Communication - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis Treat immediately if …
Medications and Gluten | FDA - U.S. Food and Drug Administration
Medications and GlutenThe majority of orally administered drug products either contain no gluten or virtually no gluten. FDA has issued a draft guidance on Gluten in Drug Products and Associated ...
FDA Proposes Ending Use of Oral Phenylephrine as OTC Monograph …
FDA is proposing to end the use of oral phenylephrine as an active ingredient from OTC Monograph M012 for the temporary relief of nasal congestion because the agency determined it is not effective.
FDA Approves First Medication to Help Reduce Allergic Reactions to ...
The FDA approved a new medication for the reduction of allergic reactions that may occur with accidental exposure to one or more foods.